Latest News and Press Releases

Testing will be available through CLX Health’s TrustAssure™ Global Testing Platform for international travelers from New York and New Jersey who will need to complete testing immediately prior to...

Total third quarter revenue of $32.8 million, a record quarterly high, increased 94% year-over-year Consolidated quarterly gross margin was 49% versus 26% in the previous year period, confirming...

NEW YORK, NY, June 01, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, announced today that it will report third quarter 2021 financial results...

Company’s specimen collection kit now available for use in COVID-19 testing in the U.S. Sample collection kit can be used with PCR based molecular diagnostic or antigen-based testing platforms ...

NEW YORK, NY, March 17, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, today announced that management will present at the KeyBanc Capital...

Total second quarter revenue of $31.5 million increased 62% year-over-year on continued recovery and expansion from impact of COVID-19 pandemicSecond quarter clinical laboratory revenue of $24.0...

NEW YORK, NY, March 04, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced that the Company will present...

Results indicate that GENFLEX meets new FDA guidance calling for COVID-19 test developers to assess the impact of viral mutations on testing results Company also publishes new corporate white...

NEW YORK, NY, March 01, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, announced today that it will report second...

NEW YORK, NY, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced the recent issuance of U.S....